These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8754189)

  • 1. [Advances in the treatment of infiltrating transitional cancer of the bladder].
    Escudero Barrilero A
    Arch Esp Urol; 1996 May; 49(4):317-23; discussion 323-35. PubMed ID: 8754189
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 3. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined radiosurgical treatment of bladder carcinoma: preliminary results of a prospective trial.
    Salvi G; Balducci M; Cellini N; D'Andrea P; De Santis M; Valentini V; Romanini A
    Rays; 1985; 10(3):133-9. PubMed ID: 3843662
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cancer of the bladder].
    Escudero Barrilero A
    Arch Esp Urol; 1989; 42(1):1-7. PubMed ID: 2653234
    [No Abstract]   [Full Text] [Related]  

  • 7. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.
    Hilmy M; Bartlett JM; Underwood MA; McMillan DC
    Br J Cancer; 2005 Feb; 92(4):625-7. PubMed ID: 15726119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 in the treatment of infiltrating bladder cancer.
    Pizza G; Berton F; Casanova S; De Vinci C; Corrado F
    J Exp Pathol; 1987; 3(4):525-31. PubMed ID: 3502649
    [No Abstract]   [Full Text] [Related]  

  • 10. Twenty-three years of disease-free survival following cutaneous metastasis from a primary bladder transitional cell carcinoma.
    Gowardhan B; Mathers ME; Feggetter JG
    Int J Urol; 2004 Nov; 11(11):1031-2. PubMed ID: 15509212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer: improving care with better classification and risk stratification.
    Lamm D
    J Urol; 2007 Oct; 178(4 Pt 1):1146-7. PubMed ID: 17698132
    [No Abstract]   [Full Text] [Related]  

  • 13. Current management of invasive and metastatic transitional cell carcinoma of the bladder.
    Thrasher JB; Crawford ED
    J Urol; 1993 May; 149(5):957-72. PubMed ID: 8483247
    [No Abstract]   [Full Text] [Related]  

  • 14. High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).
    Pansadoro V; Emiliozzi P; depaula F; Scarpone P; Pizzo M; Federico G; Martini M; Pansadoro A; Sternberg CN
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):223-7. PubMed ID: 16767936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and bladder cancer.
    Hogan TF; Lamm DL; Riggs DR; Ducatman AM
    W V Med J; 2001; 97(1):29-31. PubMed ID: 11257833
    [No Abstract]   [Full Text] [Related]  

  • 16. Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
    Zietman AL; Shipley WU; Kaufman DS; Esrig D; Lytton B
    Contemp Urol; 1995 Jul; 7(7):23-4, 29, 32, passim. PubMed ID: 10150577
    [No Abstract]   [Full Text] [Related]  

  • 17. Superficial bladder cancer: the role of molecular markers in the treatment of high-risk superficial disease.
    Malkowicz SB
    Semin Urol Oncol; 1997 Aug; 15(3):169-78. PubMed ID: 9394912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting bacillus Calmette-Guerin immunotherapy effectiveness.
    Griffith TS
    J Urol; 2007 Dec; 178(6):2247-8. PubMed ID: 17936825
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.